Joshua J Hamey, Sinja Rakow, Caroline Bouchard, Johanna M Senst, Peter Kolb, Uta-Maria Bauer, Marc R Wilkins, Gene Hart-Smith
{"title":"对PRMT6底物识别的系统研究揭示了广泛的特异性,偏爱RG基序或基本的大块残基。","authors":"Joshua J Hamey, Sinja Rakow, Caroline Bouchard, Johanna M Senst, Peter Kolb, Uta-Maria Bauer, Marc R Wilkins, Gene Hart-Smith","doi":"10.1111/febs.15837","DOIUrl":null,"url":null,"abstract":"<p><p>Protein arginine methyltransferase 6 (PRMT6) catalyses the asymmetric dimethylation of arginines on numerous substrate proteins within the human cell. In particular, PRMT6 methylates histone H3 arginine 2 (H3R2) which affects both gene repression and activation. However, the substrate specificity of PRMT6 has not been comprehensively analysed. Here, we systematically characterise the substrate recognition motif of PRMT6, finding that it has broad specificity and recognises the RG motif. Working with a H3 tail peptide as a template, on which we made 204 amino acid substitutions, we use targeted mass spectrometry to measure their effect on PRMT6 in vitro activity. We first show that PRMT6 methylates R2 and R8 in the H3 peptide, although H3R8 is methylated with lower efficiency and is not an in vivo PRMT6 substrate. We then quantify the effect of 194 of these amino acid substitutions on methylation at both H3R2 and H3R8. In both cases, we find that PRMT6 tolerates essentially any amino acid substitution in the H3 peptide, but that positively charged and bulky residues are preferred near the target arginine. We show that PRMT6 also has preference for glycine, but only in the position immediately following the target arginine. This indicates that PRMT6 recognises the RG motif rather than the RGG motif. We further confirm this preference for the RG motif on another PRMT6 substrate, histone H4R3. This broad specificity and recognition of RG rather than RGG are distinctive among the PRMT family and has implications for the development of drugs to selectively target PRMT6. DATABASES: Panorama Public (https://panoramaweb.org/PRMT6motif.url); ProteomeXchange (PXD016711).</p>","PeriodicalId":12261,"journal":{"name":"FEBS Journal","volume":"288 19","pages":"5668-5691"},"PeriodicalIF":5.5000,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/febs.15837","citationCount":"5","resultStr":"{\"title\":\"Systematic investigation of PRMT6 substrate recognition reveals broad specificity with a preference for an RG motif or basic and bulky residues.\",\"authors\":\"Joshua J Hamey, Sinja Rakow, Caroline Bouchard, Johanna M Senst, Peter Kolb, Uta-Maria Bauer, Marc R Wilkins, Gene Hart-Smith\",\"doi\":\"10.1111/febs.15837\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Protein arginine methyltransferase 6 (PRMT6) catalyses the asymmetric dimethylation of arginines on numerous substrate proteins within the human cell. In particular, PRMT6 methylates histone H3 arginine 2 (H3R2) which affects both gene repression and activation. However, the substrate specificity of PRMT6 has not been comprehensively analysed. Here, we systematically characterise the substrate recognition motif of PRMT6, finding that it has broad specificity and recognises the RG motif. Working with a H3 tail peptide as a template, on which we made 204 amino acid substitutions, we use targeted mass spectrometry to measure their effect on PRMT6 in vitro activity. We first show that PRMT6 methylates R2 and R8 in the H3 peptide, although H3R8 is methylated with lower efficiency and is not an in vivo PRMT6 substrate. We then quantify the effect of 194 of these amino acid substitutions on methylation at both H3R2 and H3R8. In both cases, we find that PRMT6 tolerates essentially any amino acid substitution in the H3 peptide, but that positively charged and bulky residues are preferred near the target arginine. We show that PRMT6 also has preference for glycine, but only in the position immediately following the target arginine. This indicates that PRMT6 recognises the RG motif rather than the RGG motif. We further confirm this preference for the RG motif on another PRMT6 substrate, histone H4R3. This broad specificity and recognition of RG rather than RGG are distinctive among the PRMT family and has implications for the development of drugs to selectively target PRMT6. DATABASES: Panorama Public (https://panoramaweb.org/PRMT6motif.url); ProteomeXchange (PXD016711).</p>\",\"PeriodicalId\":12261,\"journal\":{\"name\":\"FEBS Journal\",\"volume\":\"288 19\",\"pages\":\"5668-5691\"},\"PeriodicalIF\":5.5000,\"publicationDate\":\"2021-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1111/febs.15837\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"FEBS Journal\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1111/febs.15837\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/4/14 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"FEBS Journal","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1111/febs.15837","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/4/14 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 5
摘要
蛋白精氨酸甲基转移酶6 (PRMT6)在人类细胞内催化精氨酸在多种底物蛋白上的不对称二甲基化。特别是,PRMT6甲基化组蛋白H3精氨酸2 (H3R2),影响基因的抑制和激活。然而,PRMT6的底物特异性尚未得到全面分析。在这里,我们系统地表征了PRMT6的底物识别基序,发现它具有广泛的特异性,并识别RG基序。以H3尾肽为模板,在其上置换204个氨基酸,利用靶向质谱法测定其对PRMT6体外活性的影响。我们首先发现PRMT6甲基化了H3肽中的R2和R8,尽管H3R8的甲基化效率较低,并且不是体内PRMT6的底物。然后,我们量化了194个这些氨基酸取代对H3R2和H3R8甲基化的影响。在这两种情况下,我们发现PRMT6基本上可以耐受H3肽中的任何氨基酸取代,但带正电的大块残基更倾向于靠近目标精氨酸。我们发现PRMT6也对甘氨酸有偏好,但只在目标精氨酸紧接着的位置。这表明PRMT6识别RG基序而不是RGG基序。我们进一步证实了RG基序在另一个PRMT6底物组蛋白H4R3上的这种偏好。这种广泛的特异性和对RG而不是RGG的识别在PRMT家族中是独特的,这对选择性靶向PRMT6的药物的开发具有重要意义。数据库:Panorama Public (https://panoramaweb.org/PRMT6motif.url);ProteomeXchange (PXD016711)。
Systematic investigation of PRMT6 substrate recognition reveals broad specificity with a preference for an RG motif or basic and bulky residues.
Protein arginine methyltransferase 6 (PRMT6) catalyses the asymmetric dimethylation of arginines on numerous substrate proteins within the human cell. In particular, PRMT6 methylates histone H3 arginine 2 (H3R2) which affects both gene repression and activation. However, the substrate specificity of PRMT6 has not been comprehensively analysed. Here, we systematically characterise the substrate recognition motif of PRMT6, finding that it has broad specificity and recognises the RG motif. Working with a H3 tail peptide as a template, on which we made 204 amino acid substitutions, we use targeted mass spectrometry to measure their effect on PRMT6 in vitro activity. We first show that PRMT6 methylates R2 and R8 in the H3 peptide, although H3R8 is methylated with lower efficiency and is not an in vivo PRMT6 substrate. We then quantify the effect of 194 of these amino acid substitutions on methylation at both H3R2 and H3R8. In both cases, we find that PRMT6 tolerates essentially any amino acid substitution in the H3 peptide, but that positively charged and bulky residues are preferred near the target arginine. We show that PRMT6 also has preference for glycine, but only in the position immediately following the target arginine. This indicates that PRMT6 recognises the RG motif rather than the RGG motif. We further confirm this preference for the RG motif on another PRMT6 substrate, histone H4R3. This broad specificity and recognition of RG rather than RGG are distinctive among the PRMT family and has implications for the development of drugs to selectively target PRMT6. DATABASES: Panorama Public (https://panoramaweb.org/PRMT6motif.url); ProteomeXchange (PXD016711).
期刊介绍:
The FEBS Journal is an international journal devoted to the rapid publication of full-length papers covering a wide range of topics in any area of the molecular life sciences. The criteria for acceptance are originality and high quality research, which will provide novel perspectives in a specific area of research, and will be of interest to our broad readership.
The journal does not accept papers that describe the expression of specific genes and proteins or test the effect of a drug or reagent, without presenting any biological significance. Papers describing bioinformatics, modelling or structural studies of specific systems or molecules should include experimental data.